The head of the Russian “Gamaleya” Center for Research in Epidemiology and Microbiology, Alexander Ginsburg, revealed – to the “Russia Today” channel – the importance of the Russian cancer vaccine.
Ginsburg said – in a statement published on the channel’s website on Tuesday – that “the new vaccine is based on RNA, which is a therapeutic drug that prepares the immune system of patients receiving it so that the immune system begins to destroy cancer cells… After the person receives the vaccine, lymphocytes or blood cells are formed in his body.” White immune cells can recognize the antigens found on the surface of tumors. These cells merge with tumor cells and secrete enzymes, some of which penetrate the cancer cell wall and some of which enter the cancer cell and cause Destruction of its proteins, and thus the infected cell dies and decomposes.”
Ginsburg pointed out that the new treatment can eliminate tumor cells without causing any infections in the body, and that the experts at the Gamaleya Center are continuing to develop the aforementioned vaccine model, and are also working on developing new models for the prevention of cancerous diseases.
Ginsburg recently stated that he expects to receive official permits to use the cancer vaccine – which the center is developing – in January 2025.